Havens Advisors’s Medicines Co MDCO Stock Holding History

Havens Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-78,000	Closed	-$6.63M	–	40
2019 Q4	$6.63M	Buy	+78,000	New	+$5.2M	5.81%	6

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Havens Advisors's MDCO Position: Q1 2020 in Review

Havens Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 78,000 shares — an estimated $6.63M sold.

Havens Advisors first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $6.63M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Havens Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Havens Advisors sold 78,000 Medicines Co shares in Q1 2020, an estimated $6.63M.
Havens Advisors first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Havens Advisors's Medicines Co position peaked at $6.63M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Havens Advisors's 13F filing for Q1 2020, filed 21 Apr 2020.